TMEM78
Transmembrane protein 78
Also known as: TMM78_HUMAN
Protein identityUniProt · HPA
OverviewNCBI Gene
No narrative summary is available for TMEM78 in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
136 residues, UniProt reviewed canonical sequence.
>Q5T7P6|TMEM78
1 MWLDTRNLGI VISCWKGVCV PQTTTLEMFY NDNDRVEESS NSYQIRREFL LPACLPAFLS
61 FSTSFSFFLS FLPLSLSLFL PFFPSFFLSL SLSPSFLPSF LRQGLALSPR LECDGAIMIH
121 CSLNIPGSSD PPTSASLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TMEM78 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 2
- Mean surface accessibility (rSASA)
- 0.58
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD missense Z
- 0.08
OntologyGO
Cellular components
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TMEM78 as an antibody target. Whether an autoantibody or antibody against TMEM78 could matter depends on whether native TMEM78 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TMEM78 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TMEM78 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...